ATG5 and neoplasm: To characterize the role of myeloid cell autophagic pathways in tumor progression, we generated a myeloid cell-specific targeted deletion of the autophagic gene Atg5 by crossing mice carrying the lox-P flanked Atg5 allele to mice carrying lysozyme M (LysM) promoter-driven Cre recombinase [16].